🇫🇷
France · FR · FR:60175591
REBLOZYL 25 mg, poudre pour solution injectable
ReimbursedATC B03XA06
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerBRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
CountryFR (France)
ATC codeB03XA06
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009302121411 flacon(s) en verre de 3 mlEUR 1.23
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "60175591",
"date_amm": "2020-06-25",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1452",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code B03XA06.
- DKReblozylBristol-Myers Squibb Pharma EEIG
- ISReblozylBristol-Myers Squibb Pharma EEIG*
- ISReblozylBristol-Myers Squibb Pharma EEIG*
- DKReblozylBristol-Myers Squibb Pharma EEIG
- PLReblozylBristol-Myers Squibb Pharma EEIG
- PLReblozylBristol-Myers Squibb Pharma EEIG
- NOReblozylBristol-Myers Squibb Pharma EEIG (1)
- 🇺🇸ReblozylCelgene Corporation
Access this data programmatically
Query REBLOZYL 25 mg, poudre pour solution injectable and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.